HIV Policy: the Good, the Bad, and What Should Come Next

By on .

Millions of lives saved. More than 30 drugs approved. Many new infections prevented. Those are the key successes in the nearly 3-decade-old battle against HIV/AIDS, as laid out in a broad position paper by the HIV Medicine Association, the Infectious Diseases Society of America, and the American College of Physicians.


Christine Lubinski, IDSA’s vice president for global health, is among the authors of the piece, “HIV Policy—The Path Forward,” published today in Clinical Infectious Diseases.


The paper also spells out the myriad challenges that remain—a growing global AIDS epidemic, drug-resistant for long-term survivors of HIV, and unmet goals in prevention, among other problems.


The authors call for a broad array of policy steps, including federal and state support of routine HIV testing among key populations, support for evidenced-based interventions, and robust US leadership to respond the global pandemic.


Click here for the full article.

Leave a Comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.